Not all patients with neurological diseases are candidates for DMTs. Eligibility often depends on the specific diagnosis, the stage and severity of the disease, and the patient's overall health. For instance, in MS, DMTs are generally recommended for patients with relapsing-remitting MS, while their use in progressive forms of the disease is more complex and depends on individual circumstances.
